TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $8,303,000 | -22.1% | 609,195 | -6.4% | 0.64% | -32.0% |
| Q3 2021 | $10,663,000 | -47.8% | 650,995 | -46.4% | 0.94% | -38.3% |
| Q2 2021 | $20,443,000 | -54.6% | 1,214,695 | -50.8% | 1.53% | -53.9% |
| Q1 2021 | $45,078,000 | -13.7% | 2,468,695 | -14.0% | 3.31% | -11.1% |
| Q4 2020 | $52,259,000 | +11.2% | 2,871,395 | +9.0% | 3.72% | +9.0% |
| Q3 2020 | $46,978,000 | -22.1% | 2,633,295 | -21.7% | 3.42% | +0.8% |
| Q2 2020 | $60,278,000 | +11.2% | 3,361,876 | -5.9% | 3.39% | +11.4% |
| Q1 2020 | $54,209,000 | -17.9% | 3,571,076 | +6.7% | 3.04% | +19.4% |
| Q4 2019 | $66,016,000 | +21.8% | 3,345,976 | +6.1% | 2.55% | +27.3% |
| Q3 2019 | $54,222,000 | +55.1% | 3,152,470 | +59.6% | 2.00% | +63.9% |
| Q2 2019 | $34,964,000 | +8.8% | 1,975,360 | +25.2% | 1.22% | +14.8% |
| Q1 2019 | $32,143,000 | – | 1,577,960 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |